Clinical trials recruiting for CAR-T Cell Therapy

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
  NCT05858684 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• GPC3/Mesothelin-CAR-γδT Cells Against Cancers
  NCT06196294 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• MB-CART2019.1 in Refractory Multiple Sclerosis
  NCT07178431 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
  NCT05779917 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
  NCT06934447 · Phase: Phase 1 · Ages: 5 Years and older · Sex: All (male and female) · 1 location
• TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
  NCT07246304 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for CAR-T Cell Therapy often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for CAR-T Cell Therapy trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.